Research Topics
Species | Leslie T CooperSummaryAffiliation: Mayo Clinic Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Genomic and proteomic analysis of myocarditis and dilated cardiomyopathyLeslie T Cooper
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Heart Fail Clin 6:75-85. 2010..This article reviews several examples of noncandidate genomic and proteomic screening, as well as the potential strengths and pitfalls of these strategies for the evaluation of myocarditis and nonischemic DCM...
Biventricular assist device placement and immunosuppression as therapy for necrotizing eosinophilic myocarditisLeslie T Cooper
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Nat Clin Pract Cardiovasc Med 2:544-8. 2005..The only reported medical history was urinary tract infection and an ankle fracture sustained 5 months before presentation. She was receiving no medication other than estrogen patches for menopause and did not smoke or use illicit drugs...
Giant cell myocarditis. Diagnosis and treatmentL T Cooper
Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, 55905, Rochester, MN, USA
Herz 37:632-6. 2012..The long-term management of GCM patients, who initially recover, is not known and highlights the need for continuing multicenter collaborative clinical investigations...
Republished: pathogenesis and diagnosis of myocarditisChantal Elamm
Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Postgrad Med J 88:539-44. 2012..Recent advances in the understanding of disease pathogenesis described in this review should lead to more accurate diagnostic algorithms and non-invasive tests...
Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudicationRoger J Lewis
Department of Emergency Medicine, Harbor UCLA Medical Center, 1000 West Carson Street, Torrance, California 90509, USA
Trials 12:134. 2011..We describe the design, oversight, and implementation of an adaptive, phase II, dose-finding trial evaluating K-134 for the treatment of stable, intermittent claudication...
Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group InvestigatorsL T Cooper
Department of Medicine, University of California at San Diego Medical Center, USA
N Engl J Med 336:1860-6. 1997..Idiopathic giant-cell myocarditis is a rare and frequently fatal disorder. We used a multicenter data base to define the natural history of giant-cell myocarditis and the effect of treatment...
Giant cell and granulomatous myocarditisLeslie T Cooper
Mayo Clinic College of Medicine, Rochester, MN 55906, USA
Heart Fail Clin 1:431-7. 2005
A pilot study to assess the use of protein a immunoadsorption for chronic dilated cardiomyopathyLeslie T Cooper
Cardiovascular Division, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
J Clin Apher 22:210-4. 2007..Even without IVIG substitution, IA for the treatment of chronic DCM is associated with improved QOL up to 6 months after treatment. A randomized, sham-controlled trial is required to confirm the benefits of IA for DCM...
Acute heart failure due to fulminant and giant cell myocarditisLeslie T Cooper
College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
Herz 31:767-70. 2006....
A prospective, case-control study of tobacco dependence in thromboangiitis obliterans (Buerger's Disease)Leslie T Cooper
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
Angiology 57:73-8. 2006..03). In contrast to case reports of extreme tobacco dependence in the TAO population, the degree of tobacco dependence in subjects with TAO is similar to that in subjects with CAD...
The roles of selenium and mercury in the pathogenesis of viral cardiomyopathyLeslie T Cooper
Department of Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
Congest Heart Fail 13:193-9. 2007..Based on recent studies, the authors propose a novel paradigm for the pathogenesis of viral DCM that incorporates trace element imbalance and its interactions with the cellular physiology of viral-induced cardiomyocyte dysfunction...
Peripheral arterial disease: diagnosis and managementFaisel A Arain
Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Mayo Clin Proc 83:944-49; quiz 949-50. 2008..As a general rule, patients with lifestyle-limiting claudication who do not respond to medical management or those with critical limb ischemia should be referred to a vascular specialist for consideration of revascularization...
Usefulness of immunosuppression for giant cell myocarditisLeslie T Cooper
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
Am J Cardiol 102:1535-9. 2008..Additionally, withdrawal of immunosuppression can be associated with fatal GCM recurrence...
The natural history and role of immunoadsorption in dilated cardiomyopathyLeslie T Cooper
Cardiovascular Division, Mayo Clinic, Rochester, Minnesota 55905, USA
J Clin Apher 20:256-60. 2005
Proteinuria in a placebo-controlled study of basic fibroblast growth factor for intermittent claudicationL T Cooper
Mayo Clinic and Foundation, Cardiovascular Division, Rochester, MN 55905, USA
Vasc Med 6:235-9. 2001..Future clinical trials of bFGF protein should carefully monitor renal function and consider alternative dosing schedules and drug administration routes...
Giant cell myocarditis: diagnosis and treatmentL T Cooper
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
Herz 25:291-8. 2000..To confirm and extend these findings, a randomized trial of immunosuppression including muromonab-CD3, cyclosporine, and steroids is underway...
National Institutes of Health-sponsored workshop on inflammation and immunity in dilated cardiomyopathyLeslie T Cooper
Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
Mayo Clin Proc 81:199-204. 2006..The major recommendations from the members of the workshop are organized according to the following themes: cardiotropic viruses, innate and acquired immune responses, environmental factors, novel diagnostics, and novel therapeutics...
A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditisYuji Okura
Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
J Am Coll Cardiol 41:322-9. 2003..CONCLUSIONS: Transplant-free survival is better for patients with CS than for IGCM diagnosed by EMB. Presentation with heart failure predicted IGCM, and presentation with heart block or more than nine weeks of symptoms predicted CS...
Atrial giant cell myocarditis: a distinctive clinicopathologic entityBrandon T Larsen
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
Circulation 127:39-47. 2013..We describe a novel variant of GCM, primarily involving the atria, that displays distinctive clinical features and follows a more benign course than ventricular GCM...
Pathogenesis and diagnosis of myocarditisChantal Elamm
Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Heart 98:835-40. 2012..Recent advances in the understanding of disease pathogenesis described in this review should lead to more accurate diagnostic algorithms and non-invasive tests...
Coronary sarcoidosis presenting as acute coronary syndromeCarolyn S P Lam
Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
Clin Cardiol 32:E68-71. 2009..A review of the literature also suggests the need for improvement in diagnostic approaches and prospective clinical trials to establish the best management strategy for this disease...
Diagnosis and treatment of viral myocarditisJason C Schultz
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
Mayo Clin Proc 84:1001-9. 2009..Main keywords searched were myocarditis, dilated cardiomyopathy, endomyocardial biopsy, cardiac magnetic resonance imaging, and immunotherapy...
Treatment of chronic dilated cardiomyopathy with immunoadsorption using the staphylococcal A-agarose column: a comparison of immunoglobulin reduction using two different techniquesEdwin A Burgstaler
Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
J Clin Apher 22:224-32. 2007..This small study, demonstrated that a modified technique (T-2) with superior fluid balance should be used when treating DCM with the Immunosorba system...
MyocarditisLori A Blauwet
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
Prog Cardiovasc Dis 52:274-88. 2010..Prognosis in acute myocarditis is generally good except in patients with giant cell myocarditis. Persistent, chronic myocarditis usually has a progressive course but may respond to immunosuppression...
The role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditisRaymond C Shields
Department of Cardiology, Mayo Clinic, Rochester, MN 55905, USA
J Card Fail 8:74-8. 2002..Although these results may not apply to individuals with less aggressive disease, EMB may be used selectively to distinguish fulminant heart failure caused by GCM from other causes in which the prognosis may differ...
MyocarditisSandeep Sagar
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
Lancet 379:738-47. 2012..Findings from recent clinical trials suggest that some patients with chronic inflammatory cardiomyopathy have a progressive clinical course despite standard medical care and might improve with a short course of immunosuppression...
Noninvasive imaging in myocarditisHadi N Skouri
Cardiovascular Department, Mayo Clinic, Rochester, Minnesota 55905, USA
J Am Coll Cardiol 48:2085-93. 2006..Novel imaging modalities that are currently in preclinical development are discussed with recommendations for future clinical research...
Echocardiographic features of atrial myocarditis with giant cells: a case reportKwan-K Law
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
J Am Soc Echocardiogr 17:1073-6. 2004..After immunosuppressive therapy, the endomyocardial thickening completely resolved, but the restrictive cardiomyopathy did not reverse...
Statistical analysis of relative labeled mass spectrometry data from complex samples using ANOVAAnn L Oberg
Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA
J Proteome Res 7:225-33. 2008..The modeling approach, implementation, and useful visualization tools are demonstrated via a case study of complex biological samples assessed using the iTRAQ relative labeling protocol...
Spontaneous myocarditis mimicking human disease occurs in the presence of an appropriate MHC and non-MHC background in transgenic miceVeena Taneja
Department of Immunology, Mayo Clinic College of Medicine, 200 First Street S W, Rochester, MN 55905, USA
J Mol Cell Cardiol 42:1054-64. 2007..This model of myocarditis occurs predominantly in female mice and may provide insight into the pathogenesis of heart disease in women...
Greater symptom duration predicts response to immunomodulatory therapy in dilated cardiomyopathyChristopher Stanton
Department of Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
Int J Cardiol 128:38-41. 2008..We hypothesized that clinical response to immunomodulation would be dependent on symptom duration. Pooled immunomodulatory trial data was used to test this hypothesis...
Myocardial recovery in peripartum cardiomyopathy: prospective comparison with recent onset cardiomyopathy in men and nonperipartum womenLeslie T Cooper
Mayo Clinic, Rochester, MN, USA
J Card Fail 18:28-33. 2012..This was examined through an analysis of outcomes in the Intervention in Myocarditis and Acute Cardiomyopathy 2 (IMAC2) registry...
Eosinophilic-lymphocytic myocarditis after smallpox vaccinationJoseph G Murphy
Division of Cardiovascular Diseases, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA
Lancet 362:1378-80. 2003..A better understanding of the aberrant immune mechanism of myocyte injury after smallpox vaccination might improve the risk/benefit assessment for people considering smallpox vaccination and better smallpox vaccines in the future...
Early identification of cardiovascular risk using genomics and proteomicsIftikhar J Kullo
Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Nat Rev Cardiol 7:309-17. 2010..In this article, we use the specific example of atherosclerosis to discuss the role of genomics and proteomics in cardiovascular risk assessment...
Increased risk of peripheral arterial disease in polymyalgia rheumatica: a population-based cohort studyKenneth J Warrington
Department of Medicine, Division of Rheumatology, Mayo Clinic, Rochester, MN 55905, USA
Arthritis Res Ther 11:R50. 2009..The present study was conducted to determine whether patients with polymyalgia rheumatica (PMR) are at an increased risk of peripheral arterial disease (PAD)...
Cardiac calcified amorphous tumor in a patient presenting for ventricular tachycardia ablation: intracardiac echocardiogram diagnosis and managementAmmar Habib
Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
J Interv Card Electrophysiol 29:175-8. 2010..The imaging characteristics and management are described...
Use of intermittent pneumatic compression for treatment of upper extremity vascular ulcersDavid H Pfizenmaier
Division of Vascular Medicine and Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
Angiology 56:417-22. 2005..A prospective, randomized, sham-controlled study of IPC is needed to determine whether IPC treatment improves wound healing compared to standard medical care...
Takayasu's arteritis: operative results and influence of disease activityCharles E Fields
Division of Vascular Surgery, Mayo Clinic and Foundation, Rochester, Minn, USA
J Vasc Surg 43:64-71. 2006..Patients with active disease requiring operation are more likely to require revision or develop progressive symptomatic disease at another site. Long-term survival is excellent, regardless of disease activity at the time of operation...
Median arcuate ligament syndrome: a nonvascular, vascular diagnosisNedaa Skeik
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
Vasc Endovascular Surg 45:433-7. 2011..We illustrate the current gaps in our knowledge of MALS with the case of a 51-year-old woman with a 4-year history of chronic abdominal pain who responded to a combination of ganglion resection and celiac artery reconstruction...
Iron and peripheral arterial disease: revisiting the iron hypothesis in a different lightGautam Ramakrishna
Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN 55905, USA
Vasc Med 8:203-10. 2003..This background will be expanded upon to provide insights into ongoing studies and paths for future investigations into the role of iron and peripheral arterial disease...
Transplantation for myocarditis: a controversy revisitedEdward D Moloney
Department of Respiratory Medicine, Mater Misericordiae University Hospital, Dublin, Ireland
J Heart Lung Transplant 24:1103-10. 2005..We present the case of a 42-year-old man with recurrence of GCM 8 years after transplantation and review the literature on the role of cardiac transplantation for patients with myocarditis...
Cautious interpretation of data regarding myopericarditis associated with smallpox vaccinationAppor S Gami
J Am Coll Cardiol 45:160; author reply 160-1. 2005
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society ofLeslie T Cooper
J Am Coll Cardiol 50:1914-31. 2007
Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's disease)Leslie T Cooper
J Am Coll Cardiol 44:2410-1. 2004
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of CardiologyLeslie T Cooper
Mayo Clinic
Circulation 116:2216-33. 2007
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of Leslie T Cooper
American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231, USA
Eur Heart J 28:3076-93. 2007
Viral infection, inflammation, and the risk of idiopathic dilated cardiomyopathy: can the fire be extinguished?Leslie T Cooper
Am J Cardiol 90:751-4. 2002
Total lymphoid irradiation: new therapeutic option for refractory giant cell myocarditisTajinder P Singh
Department of Pediatrics, Children s Hospital of Michigan, Wayne State University School of Medicine, Detroit, Michigan, USA
J Heart Lung Transplant 23:492-5. 2004..This novel treatment should be considered in all patients with GCM who do not have histologic remission with the currently employed anti-T-cell immunosuppression...
Research Grants
- Inflammation and Immunity in Dilated CardiomyopathyLeslie Cooper; Fiscal Year: 2004..The long-term overall goal of this workshop is to translate advances in molecular and cellular mechanisms of disease into improvements in the diagnosis and treatment of patients with DCM. ..
- Giant Cell Myocarditis Treatment Trial Pilot StudyCOOPER LESLIE; Fiscal Year: 2005..Abstract Not Provided ..
